TP53 gene mutations affect lung cancer treatment response, study shows

Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with different mutations that vary according to factors such as smoking and ethnicity.
Morning Overview on MSN

A phase 1/2 trial just reported exceptional disease control on pancreatic cancer using daraxonrasib — a targeted drug aimed at the mutation doctors once called untreatable

For roughly four decades, oncologists had a grim shorthand for the most common genetic driver of pancreatic cancer: undruggable. The KRAS protein, mutated in about 90 percent of pancreatic tumors, resisted every small molecule researchers threw at it.

When should you get a mammogram to screen for breast cancer? Experts clarify

The new breast cancer screening guidelines are creating mixed signals on when to start screening. Medical News Today spoke to 2 experts to explain the latest changes.
Medical Xpress

Novel immunotherapy targets common cancer mutation, offering hope for lung and prostate cancer patients

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as lung and prostate cancer. This approach has effectively ...